Legendary investor Warren Buffett advises to be fearful when others are greedy and greedy when others are fearful. Telix Pharmaceuticals Ltd (TLX) stock entered oversold territory with an RSI reading of 29.5, indicating potential buying opportunities. The 52-week range for TLX is $9.475 to $20.93 per share, currently trading at $9.55. Investors should monitor RSI levels for potential entry points. Check out 9 other oversold stocks for more opportunities.

Read more at Nasdaq: Telix Pharmaceuticals is Now Oversold (TLX)